Consequently, although obesity affects hundreds of millions of people globally, GLP-1 therapies currently reach only a small fraction of eligible patients, underscoring the substantial unmet need for more convenient, scalable, and accessible treatment options
Therefore it is not known what the possible side effects are or how serious they could be
Patients often face months of denials, step therapy requirements, and exhaustive documentation before any authorization
Impact of Semaglutide on Anxiety-Related Behaviors in Diabetic Patients: A Preliminary Study
Often referred to as Ozempic face, these changes are typically related to volume loss in the cheeks and midface, along with increased skin laxity
Curcumin and quercetin modify warfarin-induced regulation of porcine CYP1A2 and CYP3A expression and activity in vitro